Multiple System Atrophy (MSA) Clinical Trial
Official title:
Multiple System Atrophy Multidisciplinary Clinic
This is a prospective cohort study to examine the disease burden of multiple system atrophy and the impact of multidisciplinary care on quality of life and caregiver burden. Data will be collected through valid rating scales completed by patients and caregivers at home or in the MSA clinic.
Study Procedures: Participants and caregivers will attend a multidisciplinary MSA clinic one day every four months. In addition to the standard of care, they will be asked to complete both online and paper questionnaires, including the following: - UMSARS (Unified MSA Rating Scale) - MSA QOL - CES-D - OHQ - Compass-31 - BIC - UPDRS - SARA - MDS Scale - CGI - MoCA Participants will be part of the study as long as they are a patient of the MSA clinic, and will be contacted for follow-up information up to five years. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05923866 -
A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy
|
Phase 2 | |
| Recruiting |
NCT02778607 -
PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK
|
||
| Completed |
NCT01485549 -
Oligomeric Alpha-synuclein in Multiple System Atrophy
|
||
| Completed |
NCT02796209 -
Norepinephrine Transporter Blockade, Autonomic Failure
|
Phase 2 | |
| Completed |
NCT04193527 -
A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients
|
Phase 3 | |
| Completed |
NCT01888185 -
Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)
|
||
| No longer available |
NCT05086094 -
Expanded Access Protocol of Verdiperstat in Patients With Multiple System Atrophy (MSA)
|